SER
Serina Therapeutics, Inc.
Serina Therapeutics, Inc. (SER) has 10 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 9, 2026.
The most active filer is Director WILSON KAREN J with 4 filings.
- Industry:Biotechnology
- CEO:Steven A. Ledger
- Employees:12
- HQ:Huntsville, AL, US
- IPO:2000-01-21
Insider Buying
$78K
reported purchases (SEC code P)
Insider Selling
$23K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$31.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Brannan Stephen K.First filing | Director | Purchase | 1,000 | $2K | Jul 9 | SEC ↗ |
Venkatesan JayFirst filing | Director | Purchase | 589 | $1K | Jun 22 | SEC ↗ |
| Director | Purchase | 5,100 | $9K | Jun 15 | SEC ↗ | |
| Director | Purchase | 5,000 | $9K | Jun 15 | SEC ↗ | |
WILSON KAREN JFirst filing | Director | Purchase | 10,000 | $18K | May 26 | SEC ↗ |
WILSON KAREN JFirst filing | Director | Purchase | 10,000 | $19K | May 26 | SEC ↗ |
Marshall Richard PeterFirst filing | Director | Purchase | 12,183 | $20K | May 22 | SEC ↗ |
Moreadith RandallFirst filing | Chief Scientific Officer | Sale | 1,500 | $6K | Dec 4 | SEC ↗ |
Moreadith RandallFirst filing | Chief Scientific Officer | Sale | 5,000 | $18K | Dec 4 | SEC ↗ |
Related companies
Serina Therapeutics, Inc. is in the Healthcare sector.